Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Menses and Tampon Use on Dapivirine Ring PK
NCT02858024Phase 1Completed
- Sponsor
- International Partnership for Microbicides
- Start
- Jan 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of dapivirine in human immunodeficiency virus infection (HIV) (2 cohorts), sponsored by International Partnership for Microbicides. Primary endpoints: Dapivirine concentrations in vaginal fluid and in plasma (No Tampons) at 28 days and Dapivirine concentrations in vaginal fluid and in plasma (With Tampons) at 28 days. Started Jan 2015; status: completed.
02
Drugs
dapivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02858024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02858024.